Automated Compounding Devices Market by Component, Product Type, Application, End-User

Description

List of Tables

[190 Pages Report] The Automated Compounding Devices Market size was estimated at USD 2.32 billion in 2023 and expected to reach USD 2.56 billion in 2024, at a CAGR 10.52% to reach USD 4.69 billion by 2030.

Global Automated Compounding Devices Market

KEY MARKET STATISTICS
Base Year [2023]	USD 2.32 billion
Estimated Year [2024]	USD 2.56 billion
Forecast Year [2030]	USD 4.69 billion
CAGR (%)	10.52%

Automated Compounding Devices Market - IMG1

The automated compounding devices are designed to prepare medications for dispensing in healthcare settings. These devices automate the process of mixing, diluting, and assembling drugs in various dosages with a high degree of precision and safety. Automated compounding devices are widely used in several areas such as oncology (for chemotherapy drug preparation), total parenteral nutrition (TPN), and high-volume workloads often found in centralized compounding facilities. The end users primarily include hospital pharmacies, compounding pharmacies, and ambulatory services due to their need for efficient and safe preparation of medications in sterile environments. Increased medication needs to manage rising incidences of chronic diseases, along with the rising focus on personalized medicine, fuels demand for more compounded medications. Additionally, the growing importance of improving pharmacological safety standards in healthcare settings incentivizes the adoption of automated compounding devices. High costs associated with the installation and maintenance of automated compounding systems hamper the growth of the automated compounding devices market. The need for skilled professionals to operate these advanced devices further complicates the implementation of automated compounding devices. Growing research and innovation directed toward creating scalable machine models that cater to varying sizes of operations, from small clinics to large hospitals, are expected to create opportunities for market growth. Furthermore, investing in research for materials that are more durable and easy to clean could aid in meeting stringent hygiene and sterility requirements.

Regional Insights

The market for automated compounding devices in the Americas is highly influenced by the healthcare infrastructure and regulatory environment in the United States and Canada. The increasing prevalence of chronic diseases, coupled with a push towards healthcare automation to enable precision and safety in medication dispensing, fuels the need for automated compounding systems. In the European Union, the market is driven by stringent regulations on medication preparation, a focus on reducing healthcare costs, and increasing adoption of technology in pharmacies and hospitals. Countries such as Germany, France, the UK, and Italy are at the forefront of adopting these devices, aiming to improve the quality of care and patient safety. The EU's interest in standardizing pharmaceutical practices across member states augments the implementation of automated compounding devices and fosters cross-border research and development initiatives. The Asia Pacific region, including countries such as China, Japan, and India, presents a promising growth opportunity for the automated compounding devices market. This region's market dynamics are driven by rapidly developing healthcare infrastructure, increasing healthcare expenditure, and a growing focus on medication safety.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Automated Compounding Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Automated Compounding Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Automated Compounding Devices Market, highlighting leading vendors and their innovative profiles. These include Amerisource Bergen Corporation, ARxIUM Inc., B. Braun SE, Baxter Healthcare Corporation, Becton, Dickinson and Company, Cantel Medical Corp., CapsulCN International Co., Ltd., Codonics Inc., Fagron N.V., ForHealth Technologies, Fresenius Kabi AG, Grifols International S.A., Health Robotics SRL, Loccioni Group, McKesson Corporation, Meditecno S.r.l., Medtronic PLC, Omnicell, Inc., Quirem Medical B.V., ScriptPro LLC, Talyst LLC, Tecan Group Ltd., Terumo Corporation, and Yuyama Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Automated Compounding Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Component
- ACD Equipment
- ACD Software
Product Type
- Intravenous Compounding Systems
- Oral Compounding Systems
- TPN Compounding Systems
Application
- Antibiotic Compounding
- Chemotherapy Compounding
- Nutrient Compounding
End-User
- Ambulatory Surgical Centers
- Hospitals
- Pharmacies
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Automated Compounding Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Automated Compounding Devices Market?

3. What are the technology trends and regulatory frameworks in the Automated Compounding Devices Market?

4. What is the market share of the leading vendors in the Automated Compounding Devices Market?

5. Which modes and strategic moves are suitable for entering the Automated Compounding Devices Market?

Product Code: MRR-BB4648AFF306

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Automated Compounding Devices Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing prevalence of chronic diseases and surgeries
  - 5.1.1.2. Rising focus on personalized medicines worldwide
  - 5.1.1.3. Growing focus on improving pharmacological safety standards in healthcare settings
- 5.1.2. Restraints
  - 5.1.2.1. High cost of development of automated compounding devices
- 5.1.3. Opportunities
  - 5.1.3.1. Growing introduction of advanced automated compounding devices
  - 5.1.3.2. Rising inclination towards oral compounding systems
- 5.1.4. Challenges
  - 5.1.4.1. Certain technical limitations associated with automated compounding devices
5.2. Market Segmentation Analysis
- 5.2.1. Product Type: Growing usage of intravenous compounding systems to automate the preparation of parenteral solutions
- 5.2.2. Application: Rising demand for automated compounding devices for nutrient compounding that help in nutrient mixtures
- 5.2.3. End-User: Expanding need for automated compounding devices across hospitals for enhancing the safety of medication preparation
- 5.2.4. Component: Increasing potential of ACD software that plays a pivotal role in the operational efficacy of automated compounding devices
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Automated Compounding Devices Market, by Component

6.1. Introduction
6.2. ACD Equipment
6.3. ACD Software

7. Automated Compounding Devices Market, by Product Type

7.1. Introduction
7.2. Intravenous Compounding Systems
7.3. Oral Compounding Systems
7.4. TPN Compounding Systems

8. Automated Compounding Devices Market, by Application

8.1. Introduction
8.2. Antibiotic Compounding
8.3. Chemotherapy Compounding
8.4. Nutrient Compounding

9. Automated Compounding Devices Market, by End-User

9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals
9.4. Pharmacies

10. Americas Automated Compounding Devices Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Automated Compounding Devices Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Automated Compounding Devices Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
- 13.3.1. New Product Launch & Enhancement
  - 13.3.1.1. Introducing Mundus Mini HD by EQUASHIELD: Redefining the Safe Handling of Hazardous Drugs
  - 13.3.1.2. Baxter Introduces ExactaMix Pro, Next-Generation Automated Nutrition Compounder, at ASHP Meeting

14. Competitive Portfolio

14.1. Key Company Profiles
- 14.1.1. Amerisource Bergen Corporation
- 14.1.2. ARxIUM Inc.
- 14.1.3. B. Braun SE
- 14.1.4. Baxter Healthcare Corporation
- 14.1.5. Becton, Dickinson and Company
- 14.1.6. Cantel Medical Corp.
- 14.1.7. CapsulCN International Co., Ltd.
- 14.1.8. Codonics Inc.
- 14.1.9. Fagron N.V.
- 14.1.10. ForHealth Technologies
- 14.1.11. Fresenius Kabi AG
- 14.1.12. Grifols International S.A.
- 14.1.13. Health Robotics SRL
- 14.1.14. Loccioni Group
- 14.1.15. McKesson Corporation
- 14.1.16. Meditecno S.r.l.
- 14.1.17. Medtronic PLC
- 14.1.18. Omnicell, Inc.
- 14.1.19. Quirem Medical B.V.
- 14.1.20. ScriptPro LLC
- 14.1.21. Talyst LLC
- 14.1.22. Tecan Group Ltd.
- 14.1.23. Terumo Corporation
- 14.1.24. Yuyama Co., Ltd.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing